Oscar Health (NYSE:OSCR) Sets New 1-Year High at $23.57

Oscar Health, Inc. (NYSE:OSCR) hit a new 52-week high during trading on Thursday . The company traded as high as $23.57 and last traded at $23.42, with a volume of 460399 shares changing hands. The stock had previously closed at $22.60.

Analysts Set New Price Targets

A number of research analysts have commented on OSCR shares. Wells Fargo & Company upped their price objective on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, June 12th. Robert W. Baird started coverage on Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. Bank of America reissued a “neutral” rating and set a $21.00 target price (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Baird R W raised Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Piper Sandler reissued an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Oscar Health has a consensus rating of “Moderate Buy” and a consensus price target of $24.17.

Oscar Health Stock Down 1.5 %

The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a 50-day moving average of $17.90 and a two-hundred day moving average of $17.55.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same period in the prior year, the company earned ($0.07) EPS. Oscar Health’s revenue for the quarter was up 44.6% on a year-over-year basis. On average, research analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The disclosure for this sale can be found here. Over the last three months, insiders sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Oscar Health

Hedge funds have recently made changes to their positions in the stock. Avalon Trust Co bought a new position in shares of Oscar Health during the first quarter worth about $69,000. Point72 Hong Kong Ltd bought a new position in shares of Oscar Health during the second quarter worth about $78,000. Quest Partners LLC bought a new position in shares of Oscar Health during the second quarter worth about $93,000. Amalgamated Bank raised its position in shares of Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after acquiring an additional 1,458 shares during the last quarter. Finally, Prevail Innovative Wealth Advisors LLC bought a new position in shares of Oscar Health during the fourth quarter worth about $92,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.